SPARC and cancer: We next assessed CRAd's CPE on SPARC-positive large T antigen-transformed microendothelial cells (HMEC-1) and WI-38-fetal lung fibroblasts that could be considered as resembling the potential characteristics of cancer-associated stromal cells.